UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060579
Receipt number R000069291
Scientific Title Efficacy of a Diabetes Onset Prevention App System Utilizing Continuous Glucose Monitoring and Artificial Intelligence in Individuals at High Risk for Type 2 Diabetes
Date of disclosure of the study information 2026/02/13
Last modified on 2026/02/04 14:53:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of a Diabetes Onset Prevention App System Utilizing Continuous Glucose Monitoring and Artificial Intelligence in Individuals at High Risk for Type 2 Diabetes

Acronym

Evaluation of an AI and Continuous Glucose Monitoring Based App to Support the Prevention of Type 2 Diabetes

Scientific Title

Efficacy of a Diabetes Onset Prevention App System Utilizing Continuous Glucose Monitoring and Artificial Intelligence in Individuals at High Risk for Type 2 Diabetes

Scientific Title:Acronym

Evaluation of an A- and Continuous Glucose Monitoring Based App to Support the Prevention of Type 2 Diabetes

Region

Japan


Condition

Condition

Prediabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

As existing evidence is limited to improvements in surrogate markers, this study will conduct a 1-year randomized controlled trial using an improved system, with diabetes incidence as the primary endpoint, to establish empirical evidence for the prevention of type 2 diabetes.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of diabetes mellitus before and after the intervention will be compared between the intervention group and the control group.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

Intervention using a continuous glucose monitoring function + AI-powered disease prevention application system

Interventions/Control_2

Standard diabetes prevention guidance

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Individuals with HbA1c < 6.5 percent and fasting blood glucose < 126 mg/dL and random blood glucose < 200 mg/dL
2. Individuals meeting condition 1 HbA1c >= 6.0 percent and fasting blood glucose >= 103 mg/dL or condition 2 HbA1c >= 6.2 percent or condition 3 fasting blood glucose >= 112 mg/dL
3. Individuals aged 20 years or older and 70 years or younger at the time of consent acquisition
4. Individuals with a BMI >= 25 kg/m2 and < 40 kg/m2
5.Individuals capable of using the smartphone application employed in the research
6. Individuals who have received an explanation of the research content and have provided consent to participate in the study

Key exclusion criteria

1.Individuals currently receiving treatment for diabetes
2.Individuals deemed inappropriate for participation by the attending physician

Target sample size

660


Research contact person

Name of lead principal investigator

1st name Masaru
Middle name
Last name Kitazawa

Organization

Graduate School of Medical and Dental Sciences, Niigata University

Division name

Department of Haematology, Endocrinology and Metabolism

Zip code

9518510

Address

754 Asahimachidori Ichibancho, Chuo-ku, Niigata City, Niigata, Japan

TEL

0253689026

Email

m-kitazawa.med@niigata-u.ac.jp


Public contact

Name of contact person

1st name Masaru
Middle name
Last name Kitazawa

Organization

Graduate School of Medical and Dental Sciences, Niigata University

Division name

Department of Haematology, Endocrinology and Metabolism

Zip code

9518510

Address

754 Asahimachidori Ichibancho, Chuo-ku, Niigata City, Niigata, Japan

TEL

0253689026

Homepage URL


Email

m-kitazawa.med@niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Niigata University Research Ethics Committee for Studies Involving Human Subjects

Address

754 Asahimachidori Ichibancho, Chuo-ku, Niigata City, Niigata, Japan

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 02 Month 04 Day

Date of IRB


Anticipated trial start date

2026 Year 02 Month 13 Day

Last follow-up date

2028 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 04 Day

Last modified on

2026 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069291